alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Subpart B of Part 591
Editorial Note: Nomenclature changes to subpart B of part 591 appear at 70 FR 31313, May 31, 2005.

§ 591.240 How are agency and employee representatives involved in the administration of the COLA and post differential programs? ( a ) OPM may establish a COLA Advisory Committee in each COLA survey area. The committees are composed of agency and employee representatives from the COLA survey area and one or more representatives from OPM.
( b ) To the extent practical, the COLA Advisory Committees coordinate and work with the Survey Implementation Committee established pursuant to *Caraballo, et al.* v. *United States,* No. 1997-0027 (D.V.I).
STEAM ELECTRIC CBI REPLACEMENT PAGE

EPA-HQ-OW-2009-0819

 DCN: SE03869.A1

THE FOLLOWING HAS BEEN REMOVED BECAUSE IT 

CONTAINS CONFIDENTIAL BUSINESS INFORMATION 

(CBI) PER 40 CFR PART 2, SUBPART B.
|         |                                                                                                                                                                                                                                                                                           |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 filed on the date hereof with the Securities and Exchange Commission (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |

|         |                                                                                                                                                      |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

|        |
|--------|
|        |  |  |  |  |
| Dated: | February 23, 2015 | By   | /s/ D. Craig Mense   |   |
|   |   |   | D. Craig Mense  |   |
|   |   |   | Chief Financial Officer  |   |
No. IV-10-026 

Contact: Victor Dricks (817) 860-8128 

 Lara Uselding (817) 276-6519 

 

June 23, 2010 

 E-Mail: OPA4.Resource@nrc.gov

NRC MONITORS ALERT AT DIABLO CANYON NUCLEAR POWER PLANT 

The Nuclear Regulatory Commission staff is monitoring an Alert issued at Diablo 

Canyon Nuclear Power Plant following the release of carbon dioxide in one room of the Unit one 

turbine building. 

The inadvertent release occurred during testing of the fire suppression system. The 

affected room was immediately sealed off following the incident. No one was injured and there is 

no current threat to the public as a result of this accident. 

The NRC resident inspectors are on site to oversee the licensee’s actions in response to 

the event. The plant’s two units are in normal operating mode. 

An Alert is the second lowest of four emergency classifications. Pacific Gas and Electric 

Company declared the Alert at 10:56 a.m. Central Time following the release of the carbon 

dioxide. 

 ### 

 NRC news releases are available through a free list serve subscription at the following Web address: 

http://www.nrc.gov/public-involve/listserver.html . The NRC homepage at www.nrc.gov also offers a SUBSCRIBE 

link. E-mail notifications are sent to subscribers when news releases are posted to NRC's Web site.

NRC NEWS

U.S. NUCLEAR REGULATORY COMMISSION

Office of Public Affairs Region IV 

 612 E. Lamar Blvd., Suite 400 

 Arlington, TX 76011-4125 

Telephone: (817) 860-8128
§ 919.335 What information must I provide before entering into a covered transaction with the OPM? Before you enter into a covered transaction at the primary tier, you as the participant must notify the OPM office that is entering into the transaction with you, if you know that you or any of the principals for that covered transaction: ( a ) Are presently excluded or disqualified;
( b ) Have been convicted within the preceding three years of any of the offenses listed in § 919.800(a) or had a civil judgment rendered against you for one of those offenses within that time period;
( c ) Are presently indicted for or otherwise criminally or civilly charged by a governmental entity (Federal, State or local) with commission of any of the offenses listed in § 919.800(a); or
( d ) Have had one or more public transactions (Federal, State, or local) terminated within the preceding three years for cause or default.
Exhibit 4.26

July 19,
2002

Stouffer
Egan
5 Waldron St.
Marblehead, MA 01945

Dear
Stouffer:

I
am pleased to confirm the details of your expanded position at Autonomy, Inc. ("Autonomy"). This letter is an amendment to the employment
letter, dated February 12, 2001, between you and Autonomy.



1

---



2

---

Your
promotion represents our opinion of your past achievements and our high expectations for the future. We look forward to mutual success. In order to confirm your agreement with and acceptance of
these terms, please sign one copy of this letter and return it to me. The other copy is for your records. If there is any matter in this letter which you wish to discuss further, please do not
hesitate to call me on +44 1223 448 000.

Sincerely,

/s/
Mike Lynch

Mike
Lynch
Chief Executive Officer

ACCEPTED AND AGREED

|Signature: |  | 
|---------- |  | 

|Name: |  | (please print)
|----- |  | --------------

|Date: |  |  | / |  | / | 
|----- |  |  | - |  | - | 
|      |  |  |   |  |   | 

3

---

QuickLinks
BISNIS Trades & Tenders, May 18, 1998

----

INTERNATIONAL COPYRIGHT, U.S. & FOREIGN COMMERCIAL SERVICE AND U.S.DEPARTMENT OF STATE, 1997.  ALL RIGHTS RESERVED OUTSIDE OF THE UNITEDSTATES.
THE BUSINESS INFORMATION SERVICE FOR THE NEWLY INDEPENDENT STATES (BISNIS)HAS CREATED THE BISNIS TRADES AND TENDERS ELECTRONIC NEWSLETTER TO HELP U.S.COMPANIES FIND BUSINESS OPPORTUNITIES IN THE EXPANDING MARKETS OF THE NEWLYINDEPENDENT STATES (NIS) OF THE FORMER SOVIET UNION.
THESE OPPORTUNITIES ARE PROVIDED SOLELY AS AN INFORMATIONAL SERVICE AND DONOT REPRESENT AN ENDORSEMENT BY THE U.S. DEPARTMENT OF COMMERCE.VERIFICATION OF LEADS IS THE RESPONSIBILITY OF THE READER. BISNIS MAY CONSIDEROTHER PRIVATE SECTOR-GENERATED TRADE LEADS AND TENDERS, IN ELECTRONIC FORMONLY, AND PUBLISH ON A SPACE-AVAILABLE BASIS. PLEASE SEND YOUR LEADS TO[email protected]
#### § 23.2 Contact person.

Tim Coss, Office of Administrative Services Operations, U.S. Department of Commerce (H2063), 14th and Constitution Ave., NW., Washington, DC 20230, Telephone (202) 377-2108.
[Federal Register Volume 84, Number 17 (Friday, January 25, 2019)]
[Notices]
[Pages 369-370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00157]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Cell Biology Integrated Review Group; Nuclear 
and

[[Page 370]]

Cytoplasmic Structure/Function and Dynamics Study Section.
    Date: January 31, 2019.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites Hotel, 4300 Military Road, Washington, DC 
20015.
    Contact Person: Jessica Smith, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, <a href="/cdn-cgi/l/email-protection#e8828d9b9b818b89c69b85819c80dea8868180c68f879e"><span class="__cf_email__" data-cfemail="9df7f8eeeef4fefcb3eef0f4e9f5abddf3f4f5b3faf2eb">[email protected]</span></a>.

    This meeting notice is being published less than 15 days in 
advance of the meeting due to the partial Government shutdown of 
December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 18, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00157 Filed 1-24-19; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 23
 
 Consent of Independent Registered Public Accounting Firm
 
 The Board of Directors
 HSBC Finance Corporation
  We consent to the incorporation by reference in the registration statements (No. 333-134419 and No. 333-134419-01) on Form S-3 of HSBC Credit Card Master Note Trust (USA) I of our attestation report dated March 28, 2011 with respect to each of HSBC Finance Corporation, as Servicer, HSBC Card Services Inc., and HSBC Technology & Services (USA) Inc. (the “HSBC Companies) and its assessment of compliance with the servicing criteria set forth in Item 1122(d) of the Securities and Exchange Commission’s Regulation AB applicable to the servicing of credit card receivables related to the HSBC Credit Card Master Note Trust (USA) I’s asset-backed securitization transactions and securities publicly issued on or after January 1, 2006 (the Platform), except for the servicing criteria identified in Schedule I of the “Report on Compliance With Applicable Servicing Criteria Pursuant To Item 1122 of Regulation AB Under the Securities Exchange Act of 1934”(Management’s Report) as “Not Applicable” which each of the individual HSBC Companies has determined are not applicable to the activities performed with respect to the Platform, as of and for the year ended December 31, 2010. Our attestation report appears in the December 31, 2010 annual report on Form 10-K of HSBC Credit Card Master Note Trust (USA) I.
 
 
 /s/ KPMG
 March 28, 2011
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK RC2 Special Emphasis Panel.                    

*Date:*                         February 15, 2019.                    

*Time:*                         3:00 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).                    

*Contact Person:*                         Peter J. Kozel, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7009, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-594-4721,                         *jerkinsa@niddk.nih.gov*.                    
      ( print page 482)    
This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: January 24, 2019.

Melanie Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2019-00290 Filed 1-29-19; 8:45 am]

 BILLING CODE 4140-01-P
O.M.B. No. 2070-0012 Approval Expires 10/31/96 

### I Agency Use Date of Receipt 

# I

~ 

# FUIR U.S. Environmental Protection Agency I NOTICE OF COMMENCEMENT oF 

# I 

# I

# ~#~ri~ MANUFACTURE OR 

### IMPORT(4OCFR~l2O.lO2) 

# I Part I- SUBMflTER IDENTIFICATION I Manufacturer/ Name ofAuthorized Official Mailing Address (number and street) Importer (in U.S.) Company Name City, State, ZIP code Technical Contact (in U.S.) Name Telephone Number 

## Part II

- 

### Premanufacture Notice (PMN) “P” Case 

## Number: Part III

- 

### Check 

## the appropriate box and provide the exact date of manufacture or importation: 

# U First 

### Commercial Manufacture** 

# El First Commercial lmportation*** date: date: Date ofcommencement isthe date of completion of non-exempt manufacture of the firstamount(batch, drum, etc.) ~Forimporters, the date ofcommencement is the date that the new chemical substance clears U.S. customs. 

## Part IV

- 

### Manufacturing 

## PlantSite(s) or Importing Site(s): (Importers, provide street address of destination) 

# 1CBr PartV

- 

### Specific Chemical 

## Identity: (For Consolidated submissions, each substance must have a separate NOC form withthe specific identity of each chemical substance.)

ICBI 

## Part VI

- 

## Generic Chemical Name (if chemical identityis claimed CBI*) 

## Part VII

- 

### Substance identity Confidentiality Status:

- I wish to continue to claim the substance identity confidential and the substantiation to support this claim is attached. Failure to submitthe required substantiation in accordance with 40 CFR 720.85(b) will result in awaiverof yourclaim. I previously claimed the substance identity as confidential and hereby relinquish that claim. 

# EJ I did notclaim the substance identity as confidential in my original PMN submission. You must submit yourcompleted notice no laterthan 30 calendar days afterthe first date of commercial manufacture/importation tothe address shown below: U.S. Environmental Protection Agency OPPT Document Control Office (7407M) 1200 

### Pennsylvania Ave., NW Washington, D.C. 20460 

### ATTN: Notice of Commencement Signature of authorized official Date Note: CBI

- refers to theterm ~Confidential Business Information”. Mark (X) in the box if the information isto be held Confidential. EPA Form 7710-56 (8-95)
# L_2020210EN.01007401.xml

| 2.7.2020 | EN | Official Journal of the European Union | L 210/74 |
| --- | --- | --- | --- |

2.7.2020

EN

Official Journal of the European Union

L 210/74

---

DECISION OF THE EEA JOINT COMMITTEE No 89/2019

of 29 March 2019

amending Annex XIII (Transport) to the EEA Agreement [2020/837]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Implementing Regulation (EU) 2019/103 of 23 January 2019 amending Implementing Regulation (EU) 2015/1998 as regards clarification, harmonisation and simplification as well as strengthening of certain specific aviation security measures (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Implementing Regulation (EU) 2019/103 of 23 January 2019 amending Implementing Regulation (EU) 2015/1998 as regards clarification, harmonisation and simplification as well as strengthening of certain specific aviation security measures (1) is to be incorporated into the EEA Agreement.

| (2) | Annex XIII to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex XIII to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 66he (Commission Implementing Regulation (EU) 2015/1998) of Annex XIII to the EEA Agreement:

| ‘— | 32019 R 0103: Commission Implementing Regulation (EU) 2019/103 of 23 January 2019 (OJ L 21, 24.1.2019, p. 13).’ |
| --- | --- |

‘—

32019 R 0103: Commission Implementing Regulation (EU) 2019/103 of 23 January 2019 (OJ L 21, 24.1.2019, p. 13).’

Article 2

The text of Implementing Regulation (EU) 2019/103 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 30 March 2019, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 29 March 2019.

For the EEA Joint Committee

The President

Claude MAERTEN

---

(1)  
  OJ L 21, 24.1.2019, p. 13.

1

(*1)  No constitutional requirements indicated.

*1

---
§ 719.4 Violations and sanctions under the Act not subject to proceedings under the CWCR. ( a ) *Criminal penalties for development or use of a chemical weapon.* Any person who violates 18 U.S.C. 229 shall be fined, or imprisoned for any term of years, or both. Any person who violates 18 U.S.C. 229 and by whose action the death of another person is the result shall be punished by death or imprisoned for life.
( b ) *Civil penalty for development or use of a chemical weapon.* The Attorney General may bring a civil action in the appropriate United States district court against any person who violates 18 U.S.C. 229 and, upon proof of such violation by a preponderance of the evidence, such person shall be subject to pay a civil penalty in an amount not to exceed $100,000 for each such violation.
( c ) *Criminal forfeiture.* ( 1 ) Any person convicted under section 229A(a) of Title 18 of the United States Code shall forfeit to the United States irrespective of any provision of State law: ( i ) Any property, real or personal, owned, possessed, or used by a person involved in the offense;
( ii ) Any property constituting, or derived from, and proceeds the person obtained, directly or indirectly, as the result of such violation; and
( iii ) Any of the property used in any manner or part, to commit, or to facilitate the commission of, such violation.
( 2 ) In lieu of a fine otherwise authorized by section 229A(a) of Title 18 of the United States Code, a defendant who derived profits or other proceeds from an offense may be fined not more than twice the gross profits or other proceeds.
( d ) *Injunction.* ( 1 ) The United States may, in a civil action, obtain an injunction against: ( i ) The conduct prohibited under section 229 or 229C of Title 18 of the United States Code; or
( ii ) The preparation or solicitation to engage in conduct prohibited under section 229 or 229D of Title 18 of the United States Code.
( 2 ) In addition, the United States may, in a civil action, restrain any violation of section 306 or 405 of the Act, or compel the taking of any action required by or under the Act or the Convention.
## SUBTITLE I—FEDERAL PROPERTY AND ADMINISTRATIVE SERVICES

Chapter
Sec.
1.
GENERAL
101
3.
ORGANIZATION OF GENERAL SERVICES ADMINISTRATION
301
5.
PROPERTY MANAGEMENT
501
7.
FOREIGN EXCESS PROPERTY
701
9.
URBAN LAND USE
901
11.
SELECTION OF ARCHITECTS AND ENGINEERS
1101
13.
PUBLIC PROPERTY
1301
EMPLOYER STATUS DETERMINATION

ANN ARBOR RAILROAD COMPANY

This is the decision of the Railroad Retirement Board regarding the

status of the Ann Arbor Railroad Company as an employer under the

Railroad Retirement and Railroad Unemployment Insurance Acts.

The Ann Arbor Railroad Company was held to be an employer under the

Acts effective September 21, 1895. It ceased operations March 31,

1976. Ann Arbor became bankrupt in the mid-1970's and the estate

was closed on April 4, 1984. It appears that the employees of Ann

Arbor became employees of Conrail as of March 31, 1976 . Ann Arbor

has had no employees since March 31, 1976.

Accordingly, the Board holds that the Ann Arbor Railroad Company

ceased to be an employer under the Railroad Retirement and Railroad

Unemployment Insurance Acts effective close of business April 4,

1984 .

V. M.' Speakman, Jr.

BCD 1996-44

BA # 1201
Home > NRC Library > ADAMS Public Documents

# SECY-07-0036 - Staff Comments on the Draft Recommendations of the International Commission on Radiological Protection

Accession Number: ML063420145

Date Released: Thursday, March 8, 2007

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
    - ML070370417 - SECY-07-0036 - Staff Comments on the Draft Recommendations of the International Commission on Radiological Protection (4 page(s), 2/22/2007)
    - ML070470492 - SECY-07-0036 Encl - Ltr to Jack Valentin fm Reyes re: Draft Recommendations of the International Commission on Radiological Protection (1 page(s), 2/22/2007)
    - ML070440182 - SECY-07-0036 (Enclosure 1) NRC Comments on the 2007 Draft Recommendations of the International Commission on Radiological Protection (2 page(s), 2/22/2007)
    - ML070440189 - SECY-07-0036 (Enclosure 2) Draft Recommendations of the International Commission on Radiological Protection (104 page(s), 2/13/2007)

Privacy PolicySite Disclaimer